Appendix 1. Drugs commonly prescribed in PEP regimens
| Regimen | Cost/28-day course* (AUD) |
|---|---|
| Tenofovir disoproxil fumarate 300mg (TDF) with lamivudine 300mg (3TC) | $568.80 |
| Tenofovir disoproxil fumarate/emtricitabine 300mg/200mg (Truvada® (TVD)) | $700.30 |
| TDF with 3TC and dolutegravir (DTG) | $1,211.90 |
| TDF with 3TC and raltegravir (RAL) | $1,180.80 |
| TDF with 3TC and rilpivirine (RPV) | $1,102.60 |
| TVD with DTG | $1,343.40 |
| TVD with RAL | $1,312.30 |
| TVD with RAL | $1,312.30 |
| TVD with RPV | $1,234.10 |
| TVD/RPV (Eviplera®) | $953.80 |
*Correct as of 28 July 2016, Pharmaceutical Benefits Scheme list prices.
Further information
Further information about pricing is available from www.pbs.gov.au/pbs/home
For more information on drug dosing and adverse events, please see http://arv.ashm.org.au